These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6106486)

  • 1. Animal models of anxiety and benzodiazepine actions.
    Iversen SD
    Arzneimittelforschung; 1980; 30(5a):862-8. PubMed ID: 6106486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavioral models of anxiety in animals].
    Thiebot MH
    Encephale; 1983; 9(4 Suppl 2):167B-176B. PubMed ID: 6144511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and Vogel conflict procedures.
    Brocco MJ; Koek W; Degryse AD; Colpaert FC
    Behav Pharmacol; 1990; 1(5):403-418. PubMed ID: 11175425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental models of anxiety for drug discovery and brain research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():299-321. PubMed ID: 20012406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validation of animal tests of anxiety--pharmacological implications.
    File SE
    Pol J Pharmacol Pharm; 1984; 36(5):505-12. PubMed ID: 6152493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.
    Dixon CI; Rosahl TW; Stephens DN
    Pharmacol Biochem Behav; 2008 Jul; 90(1):1-8. PubMed ID: 18313124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neurochemical profile of the septal nucleus accumbens in the anxiolytic action of tranquilizers on different models of anxiety].
    Talalaenko AN; Panfilov VIu; Vozdigan SA; Pokramovich AI; Markova OP; Okhrimenko SV
    Eksp Klin Farmakol; 1997; 60(4):7-9. PubMed ID: 9376765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
    Miklya I; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety].
    Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Shevchenko SL; Chernikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety signal withdrawal: a behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions.
    Thiébot MH; Dangoumau L; Richard G; Puech AJ
    Psychopharmacology (Berl); 1991; 103(3):415-24. PubMed ID: 1676183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Models of inhibition in animal behavior].
    Soubrie P; Chermat R; Poncelet M; Simon P
    Encephale; 1978; 4(5 Suppl):503-11. PubMed ID: 38103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
    Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
    Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptides and anxiety].
    Dantzer R
    Encephale; 1983; 9(4 Suppl 2):177B-182B. PubMed ID: 6144513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacology of a new psychotropic 2,3-benzodiazepine.
    Andrási F; Horváth K; Sineger E; Berzsenyi P; Borsy J; Kenessey A; Tarr M; Láng T; Kórösi J; Hámori T
    Arzneimittelforschung; 1987 Oct; 37(10):1119-24. PubMed ID: 2893623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.